Dr Reddy’s Laboratories get DCGI nod for Sputnik Phase 2 & 3 trials

coronavirus Vaccine

Dr. Reddy’s Laboratories announced it along with Russian Direct Investment Fund (RDIF) that it has received approval from the Drug Control General of India (DCGI) to conduct Phase 2 and 3 human clinical trials for Covid-19 vaccine Sputnik V in India.

Also Read | India COVID-19: Total 74,94,552 cases; Spike of 61,871 new cases

Hyderabad-based drug major said, “This will be a multi-centre and randomized controlled study, which will include safety and immunogenicity check,”

“This is a significant development that allows us to commence the clinical trial in India and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic,” Dr. Reddy’s Laboratories co-chairman and managing director GV Prasad said.

PM Narendra Modi also reviewed the pandemic situation and preparations for vaccine delivery, distribution and administration.

Also Read | Top Mass Communication Colleges in India, Here is the list

Noting that there was a decline in the daily cases and the growth rate, he cautioned people against complacency and asked them to keep up efforts to contain the pandemic.

-PTC News